Bayer Aims For Global Analgesic Market Dominance With Aleve, Aspirin

The consolidation of the Aleve (naproxen sodium) franchise under one roof - and its pairing with Bayer Aspirin - appears to be a primary driver of Bayer's acquisition of Roche Consumer Health